Tags

Type your tag names separated by a space and hit enter

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Leukemia. 2020 11; 34(11):3047-3049.L

Links

PMC Free PDF

Authors+Show Affiliations

Roeker LE
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. roekerl@mskcc.org.
Knorr DA
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pessin MS
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ramanathan LV
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Thompson MC
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leslie LA
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA.
Zelenetz AD
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mato AR
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

MeSH

AdultAgedAged, 80 and overAntibodies, NeutralizingAntibodies, ViralBetacoronavirusCOVID-19Coronavirus InfectionsCoronavirus Nucleocapsid ProteinsFemaleHumansImmunity, CellularImmunoglobulin GLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedNucleocapsid ProteinsPandemicsPhosphoproteinsPneumonia, ViralProtein BindingRNA, ViralSARS-CoV-2Severity of Illness Index

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32855439

Clinical Trial Links

Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies

Citation

Roeker, Lindsey E., et al. "Anti-SARS-CoV-2 Antibody Response in Patients With Chronic Lymphocytic Leukemia." Leukemia, vol. 34, no. 11, 2020, pp. 3047-3049.
Roeker LE, Knorr DA, Pessin MS, et al. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia. 2020;34(11):3047-3049.
Roeker, L. E., Knorr, D. A., Pessin, M. S., Ramanathan, L. V., Thompson, M. C., Leslie, L. A., Zelenetz, A. D., & Mato, A. R. (2020). Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia, 34(11), 3047-3049. https://doi.org/10.1038/s41375-020-01030-2
Roeker LE, et al. Anti-SARS-CoV-2 Antibody Response in Patients With Chronic Lymphocytic Leukemia. Leukemia. 2020;34(11):3047-3049. PubMed PMID: 32855439.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. AU - Roeker,Lindsey E, AU - Knorr,David A, AU - Pessin,Melissa S, AU - Ramanathan,Lakshmi V, AU - Thompson,Meghan C, AU - Leslie,Lori A, AU - Zelenetz,Andrew D, AU - Mato,Anthony R, Y1 - 2020/08/27/ PY - 2020/07/27/received PY - 2020/08/12/accepted PY - 2020/08/01/revised PY - 2020/8/29/pubmed PY - 2020/11/6/medline PY - 2020/8/29/entrez SP - 3047 EP - 3049 JF - Leukemia JO - Leukemia VL - 34 IS - 11 SN - 1476-5551 UR - https://www.unboundmedicine.com/medline/citation/32855439/Anti_SARS_CoV_2_antibody_response_in_patients_with_chronic_lymphocytic_leukemia_ DB - PRIME DP - Unbound Medicine ER -